| 1 | whereas | 24,933 |
| 2 | respectively.the | 18 |
| 3 | anemarsaponin | 9 |
| 4 | trans11 | 6 |
| 5 | δload | 6 |
| 6 | equilis | 4 |
| 7 | tvsp-induced | 4 |
| 8 | 'changing | 3 |
| 9 | emf+ | 3 |
| 10 | lambrusco | 3 |
| 11 | microparticle-bound | 3 |
| 12 | protrombin | 3 |
| 13 | saline/querc | 3 |
| 14 | saran | 3 |
| 15 | wheras | 3 |
| 16 | 'enjoying | 2 |
| 17 | *2-*8 | 2 |
| 18 | -686 | 2 |
| 19 | -7734 | 2 |
| 20 | -774 | 2 |
| 21 | 3,878 | 2 |
| 22 | 4,030 | 2 |
| 23 | 4,149 | 2 |
| 24 | 6-but | 2 |
| 25 | 7444 | 2 |
| 26 | 9398 | 2 |
| 27 | alva | 2 |
| 28 | brunengraber | 2 |
| 29 | crepitant | 2 |
| 30 | lopinavir-naive | 2 |
| 31 | m2,3-edge | 2 |
| 32 | mental-physical | 2 |
| 33 | mmef25-75 | 2 |
| 34 | moving-table | 2 |
| 35 | murdoch | 2 |
| 36 | n-disubstituted | 2 |
| 37 | nnos-derived | 2 |
| 38 | non-ta-assisted | 2 |
| 39 | p.w206x | 2 |
| 40 | quieting | 2 |
| 41 | second-quarter | 2 |
| 42 | software-supported | 2 |
| 43 | suryavanshi | 2 |
| 44 | taurine-supplemented | 2 |
| 45 | ultra-longacting | 2 |
| 46 | varty | 2 |
| 47 | worley | 2 |
| 48 | '56 | 1 |
| 49 | 'crossing | 1 |
| 50 | 'estimated | 1 |
| 51 | 'wormed | 1 |
| 52 | -133.00 | 1 |
| 53 | -135.00 | 1 |
| 54 | -dimethylprostaglandin | 1 |
| 55 | 0.01μg | 1 |
| 56 | 0.020-inch | 1 |
| 57 | 0.139449 | 1 |
| 58 | 0.819646 | 1 |
| 59 | 1.2.3.1 | 1 |
| 60 | 10,815 | 1 |
| 61 | 10-hole | 1 |
| 62 | 11,537 | 1 |
| 63 | 135-75 | 1 |
| 64 | 16,16-dimethyl-prostaglandin | 1 |
| 65 | 19,290 | 1 |
| 66 | 19,878.7-22,661.4 | 1 |
| 67 | 19,960.3-23,150.7 | 1 |
| 68 | 195-267 | 1 |
| 69 | 1967-march | 1 |
| 70 | 2011-with | 1 |
| 71 | 25,777 | 1 |
| 72 | 27,752 | 1 |
| 73 | 27-week-old | 1 |
| 74 | 27bp | 1 |
| 75 | 3,5-dinitrobenzoate-based | 1 |
| 76 | 37,611 | 1 |
| 77 | 381,282 | 1 |
| 78 | 38mg | 1 |
| 79 | 3dste-derived | 1 |
| 80 | 47mg | 1 |
| 81 | 5,359 | 1 |
| 82 | 5.764 | 1 |
| 83 | 5/166 | 1 |
| 84 | 50µg | 1 |
| 85 | 55ppm | 1 |
| 86 | 58,146 | 1 |
| 87 | 5g/d | 1 |
| 88 | 70/166 | 1 |
| 89 | 75/166 | 1 |
| 90 | 79.22∼139.09 | 1 |
| 91 | 79/166 | 1 |
| 92 | 9beta | 1 |
| 93 | 9β | 1 |
| 94 | abnor | 1 |
| 95 | abraso-star | 1 |
| 96 | abrograted | 1 |
| 97 | adma-induced | 1 |
| 98 | aerating | 1 |
| 99 | afterwhich | 1 |
| 100 | ageing-dependent | 1 |
| 101 | alanine-charged | 1 |
| 102 | alimenting | 1 |
| 103 | already-treated | 1 |
| 104 | am-produced | 1 |
| 105 | amaechi | 1 |
| 106 | amervac | 1 |
| 107 | anti-il-15r/il-15 | 1 |
| 108 | antidepressants-especially | 1 |
| 109 | aptt-controlled | 1 |
| 110 | ar-contained | 1 |
| 111 | assad | 1 |
| 112 | asthana | 1 |
| 113 | atrium-induced | 1 |
| 114 | attenutating | 1 |
| 115 | beller | 1 |
| 116 | bequeath | 1 |
| 117 | betamox | 1 |
| 118 | biosafe | 1 |
| 119 | breslin | 1 |
| 120 | buckner | 1 |
| 121 | byblow | 1 |
| 122 | c-rel-dependent | 1 |
| 123 | c12–c16 | 1 |
| 124 | cadmi | 1 |
| 125 | cao2/ccvo2 | 1 |
| 126 | carboxylate-functionalized | 1 |
| 127 | cardular | 1 |
| 128 | caveolin-1/galectin-3-dependent | 1 |
| 129 | cd34-negative | 1 |
| 130 | cellerix | 1 |
| 131 | cezário | 1 |
| 132 | cholester- | 1 |
| 133 | cih-mediated | 1 |
| 134 | code-named | 1 |
| 135 | coherence-based | 1 |
| 136 | collocating | 1 |
| 137 | connoting | 1 |
| 138 | cordycepin-impaired | 1 |
| 139 | corimoxazole | 1 |
| 140 | coseeding | 1 |
| 141 | coube | 1 |
| 142 | cradled | 1 |
| 143 | crag-expressing | 1 |
| 144 | cyano-functionalized | 1 |
| 145 | dadhe | 1 |
| 146 | deltanp63α-associated | 1 |
| 147 | density-enriched | 1 |
| 148 | desphospho-carboxylated | 1 |
| 149 | diblocin | 1 |
| 150 | dildl-lectin-positive | 1 |
| 151 | dilshad | 1 |
| 152 | dlg1-dependent | 1 |
| 153 | dmyc-overexpressing | 1 |
| 154 | dodds | 1 |
| 155 | doppler-monitored | 1 |
| 156 | double-echo | 1 |
| 157 | dsred-type | 1 |
| 158 | dsrna-elicited | 1 |
| 159 | egf-promoted | 1 |
| 160 | ergotamine-containing | 1 |
| 161 | erradicate | 1 |
| 162 | erythrophlesins | 1 |
| 163 | espacially | 1 |
| 164 | essentialfor | 1 |
| 165 | euron | 1 |
| 166 | exposited | 1 |
| 167 | farma-lepori | 1 |
| 168 | fatai-nyl | 1 |
| 169 | fayad | 1 |
| 170 | feed-and-bleed | 1 |
| 171 | fermentation-impaired | 1 |
| 172 | fervidicoccaceae | 1 |
| 173 | fragment-derived | 1 |
| 174 | g1-β- | 1 |
| 175 | gansky | 1 |
| 176 | gap-on-wall | 1 |
| 177 | garg | 1 |
| 178 | gem+ | 1 |
| 179 | gindi | 1 |
| 180 | graded-maintenance-dose | 1 |
| 181 | gribble | 1 |
| 182 | guileful | 1 |
| 183 | hairpin-containing | 1 |
| 184 | hanse | 1 |
| 185 | hdac-mediated | 1 |
| 186 | heparin-bound | 1 |
| 187 | high-cholesterol-fed | 1 |
| 188 | hyperosteogeny | 1 |
| 189 | hébert | 1 |
| 190 | idd9.3-encoded | 1 |
| 191 | ifn-i-independent | 1 |
| 192 | igt/low | 1 |
| 193 | il-2/ | 1 |
| 194 | immunomodulator-treated | 1 |
| 195 | improve/develop | 1 |
| 196 | improveing | 1 |
| 197 | iothalamte | 1 |
| 198 | izar | 1 |
| 199 | jawale | 1 |
| 200 | jobbins | 1 |
| 201 | k=313 | 1 |
| 202 | kilgard | 1 |
| 203 | kunkhouser | 1 |
| 204 | l178 | 1 |
| 205 | leitão | 1 |
| 206 | leu412рhe | 1 |
| 207 | limberger | 1 |
| 208 | lvdp/ | 1 |
| 209 | m1-associated | 1 |
| 210 | mac-t. | 1 |
| 211 | madni | 1 |
| 212 | makhija | 1 |
| 213 | mapquant | 1 |
| 214 | mattar | 1 |
| 215 | mdrd-estimated | 1 |
| 216 | memantine-an | 1 |
| 217 | membrano-proliferative | 1 |
| 218 | menezes | 1 |
| 219 | mid-posterior-leaflet | 1 |
| 220 | middilution | 1 |
| 221 | midinspiratory | 1 |
| 222 | mir-155-regulated | 1 |
| 223 | mmc/ | 1 |
| 224 | multimuscle | 1 |
| 225 | más | 1 |
| 226 | neccesitating | 1 |
| 227 | nehra | 1 |
| 228 | ngt/high | 1 |
| 229 | nicabate | 1 |
| 230 | non-assuring | 1 |
| 231 | non-cell-bound | 1 |
| 232 | non-hiv-1-infected | 1 |
| 233 | non-pci-related | 1 |
| 234 | noncarbamylating | 1 |
| 235 | nongeldanamycin | 1 |
| 236 | nonglycated | 1 |
| 237 | nonhydrolyzing | 1 |
| 238 | noninfarct-zone | 1 |
| 239 | ntsr2-mediated | 1 |
| 240 | nutrition..do | 1 |
| 241 | nvb+ | 1 |
| 242 | nóbrega | 1 |
| 243 | ochiai | 1 |
| 244 | omeprazole/5-hydroxy | 1 |
| 245 | oral-sex | 1 |
| 246 | orx+high-dose | 1 |
| 247 | orx+low-dose | 1 |
| 248 | outlives | 1 |
| 249 | over-activates | 1 |
| 250 | over-exceeding | 1 |
| 251 | palakkad- | 1 |
| 252 | palmitate-stimulated | 1 |
| 253 | paramita | 1 |
| 254 | pdea11 | 1 |
| 255 | peak-stress | 1 |
| 256 | pharr | 1 |
| 257 | phospho-ser474 | 1 |
| 258 | phosphor-p38 | 1 |
| 259 | phytopharm | 1 |
| 260 | pi3kβ-deficient | 1 |
| 261 | pi3kβ-knockdown | 1 |
| 262 | pkcδ-induced | 1 |
| 263 | polfa-lodz | 1 |
| 264 | post-laiv | 1 |
| 265 | postoperatively.in | 1 |
| 266 | potentalize | 1 |
| 267 | poulsen | 1 |
| 268 | poulter | 1 |
| 269 | preble | 1 |
| 270 | preenting | 1 |
| 271 | proclining | 1 |
| 272 | promutagen | 1 |
| 273 | proteqflu | 1 |
| 274 | providing-for | 1 |
| 275 | prpf | 1 |
| 276 | psi-driven | 1 |
| 277 | psychother | 1 |
| 278 | putrid-smelling | 1 |
| 279 | pwa=14 | 1 |
| 280 | quarantining | 1 |
| 281 | rajagopalan | 1 |
| 282 | rathore | 1 |
| 283 | rct-treatment | 1 |
| 284 | re-emphasizing | 1 |
| 285 | receptor-reactive | 1 |
| 286 | respectively.for | 1 |
| 287 | reunifying | 1 |
| 288 | rewriting | 1 |
| 289 | roissy | 1 |
| 290 | rovimix | 1 |
| 291 | rs11191439 | 1 |
| 292 | rs3740393 | 1 |
| 293 | ryser | 1 |
| 294 | rzdz | 1 |
| 295 | s1pr2-deficient | 1 |
| 296 | sasikumar | 1 |
| 297 | schlaff | 1 |
| 298 | schlant | 1 |
| 299 | screen-writers | 1 |
| 300 | sehlare | 1 |
| 301 | ser386-phosphorylated | 1 |
| 302 | sexhsp74and | 1 |
| 303 | shijiazhuang | 1 |
| 304 | showcasing | 1 |
| 305 | shrna-targeting | 1 |
| 306 | shugars | 1 |
| 307 | sildenafil-related | 1 |
| 308 | simoes | 1 |
| 309 | smyth | 1 |
| 310 | sol-based | 1 |
| 311 | solomkin | 1 |
| 312 | spore-adsorbed | 1 |
| 313 | sposito | 1 |
| 314 | sr-theophylline | 1 |
| 315 | stablize | 1 |
| 316 | stadler | 1 |
| 317 | staphylococcusaureus-derived | 1 |
| 318 | stauffacher | 1 |
| 319 | steering/braking | 1 |
| 320 | supella | 1 |
| 321 | superinduced | 1 |
| 322 | susrut | 1 |
| 323 | t482a/s484a | 1 |
| 324 | tamping | 1 |
| 325 | tangled | 1 |
| 326 | technometrics | 1 |
| 327 | tg2-dependent | 1 |
| 328 | tgfβ1-stimulated | 1 |
| 329 | thai-language | 1 |
| 330 | tnf-α-enhanced | 1 |
| 331 | to0.145 | 1 |
| 332 | tohfat | 1 |
| 333 | tolerance-free | 1 |
| 334 | total/individual | 1 |
| 335 | traxel | 1 |
| 336 | tryphostin | 1 |
| 337 | vdand | 1 |
| 338 | veazie | 1 |
| 339 | vegf-stimulated | 1 |
| 340 | vollmer | 1 |
| 341 | vrana | 1 |
| 342 | well-above | 1 |
| 343 | welwyn | 1 |
| 344 | whereat | 1 |
| 345 | xinzhen | 1 |
| 346 | zaidi | 1 |
| 347 | ∆camk-4 | 1 |
| 348 | ∑alkylated | 1 |
| 1 | '56 | 1 |
| 2 | 'changing | 3 |
| 3 | 'crossing | 1 |
| 4 | 'enjoying | 2 |
| 5 | 'estimated | 1 |
| 6 | 'wormed | 1 |
| 7 | *2-*8 | 2 |
| 8 | -133.00 | 1 |
| 9 | -135.00 | 1 |
| 10 | -686 | 2 |
| 11 | -7734 | 2 |
| 12 | -774 | 2 |
| 13 | -dimethylprostaglandin | 1 |
| 14 | 0.01μg | 1 |
| 15 | 0.020-inch | 1 |
| 16 | 0.139449 | 1 |
| 17 | 0.819646 | 1 |
| 18 | 1.2.3.1 | 1 |
| 19 | 10,815 | 1 |
| 20 | 10-hole | 1 |
| 21 | 11,537 | 1 |
| 22 | 135-75 | 1 |
| 23 | 16,16-dimethyl-prostaglandin | 1 |
| 24 | 19,290 | 1 |
| 25 | 19,878.7-22,661.4 | 1 |
| 26 | 19,960.3-23,150.7 | 1 |
| 27 | 195-267 | 1 |
| 28 | 1967-march | 1 |
| 29 | 2011-with | 1 |
| 30 | 25,777 | 1 |
| 31 | 27,752 | 1 |
| 32 | 27-week-old | 1 |
| 33 | 27bp | 1 |
| 34 | 3,5-dinitrobenzoate-based | 1 |
| 35 | 3,878 | 2 |
| 36 | 37,611 | 1 |
| 37 | 381,282 | 1 |
| 38 | 38mg | 1 |
| 39 | 3dste-derived | 1 |
| 40 | 4,030 | 2 |
| 41 | 4,149 | 2 |
| 42 | 47mg | 1 |
| 43 | 5,359 | 1 |
| 44 | 5.764 | 1 |
| 45 | 5/166 | 1 |
| 46 | 50µg | 1 |
| 47 | 55ppm | 1 |
| 48 | 58,146 | 1 |
| 49 | 5g/d | 1 |
| 50 | 6-but | 2 |
| 51 | 70/166 | 1 |
| 52 | 7444 | 2 |
| 53 | 75/166 | 1 |
| 54 | 79.22∼139.09 | 1 |
| 55 | 79/166 | 1 |
| 56 | 9398 | 2 |
| 57 | 9beta | 1 |
| 58 | 9β | 1 |
| 59 | abnor | 1 |
| 60 | abraso-star | 1 |
| 61 | abrograted | 1 |
| 62 | adma-induced | 1 |
| 63 | aerating | 1 |
| 64 | afterwhich | 1 |
| 65 | ageing-dependent | 1 |
| 66 | alanine-charged | 1 |
| 67 | alimenting | 1 |
| 68 | already-treated | 1 |
| 69 | alva | 2 |
| 70 | am-produced | 1 |
| 71 | amaechi | 1 |
| 72 | amervac | 1 |
| 73 | anemarsaponin | 9 |
| 74 | anti-il-15r/il-15 | 1 |
| 75 | antidepressants-especially | 1 |
| 76 | aptt-controlled | 1 |
| 77 | ar-contained | 1 |
| 78 | assad | 1 |
| 79 | asthana | 1 |
| 80 | atrium-induced | 1 |
| 81 | attenutating | 1 |
| 82 | beller | 1 |
| 83 | bequeath | 1 |
| 84 | betamox | 1 |
| 85 | biosafe | 1 |
| 86 | breslin | 1 |
| 87 | brunengraber | 2 |
| 88 | buckner | 1 |
| 89 | byblow | 1 |
| 90 | c-rel-dependent | 1 |
| 91 | c12–c16 | 1 |
| 92 | cadmi | 1 |
| 93 | cao2/ccvo2 | 1 |
| 94 | carboxylate-functionalized | 1 |
| 95 | cardular | 1 |
| 96 | caveolin-1/galectin-3-dependent | 1 |
| 97 | cd34-negative | 1 |
| 98 | cellerix | 1 |
| 99 | cezário | 1 |
| 100 | cholester- | 1 |
| 101 | cih-mediated | 1 |
| 102 | code-named | 1 |
| 103 | coherence-based | 1 |
| 104 | collocating | 1 |
| 105 | connoting | 1 |
| 106 | cordycepin-impaired | 1 |
| 107 | corimoxazole | 1 |
| 108 | coseeding | 1 |
| 109 | coube | 1 |
| 110 | cradled | 1 |
| 111 | crag-expressing | 1 |
| 112 | crepitant | 2 |
| 113 | cyano-functionalized | 1 |
| 114 | dadhe | 1 |
| 115 | deltanp63α-associated | 1 |
| 116 | density-enriched | 1 |
| 117 | desphospho-carboxylated | 1 |
| 118 | diblocin | 1 |
| 119 | dildl-lectin-positive | 1 |
| 120 | dilshad | 1 |
| 121 | dlg1-dependent | 1 |
| 122 | dmyc-overexpressing | 1 |
| 123 | dodds | 1 |
| 124 | doppler-monitored | 1 |
| 125 | double-echo | 1 |
| 126 | dsred-type | 1 |
| 127 | dsrna-elicited | 1 |
| 128 | egf-promoted | 1 |
| 129 | emf+ | 3 |
| 130 | equilis | 4 |
| 131 | ergotamine-containing | 1 |
| 132 | erradicate | 1 |
| 133 | erythrophlesins | 1 |
| 134 | espacially | 1 |
| 135 | essentialfor | 1 |
| 136 | euron | 1 |
| 137 | exposited | 1 |
| 138 | farma-lepori | 1 |
| 139 | fatai-nyl | 1 |
| 140 | fayad | 1 |
| 141 | feed-and-bleed | 1 |
| 142 | fermentation-impaired | 1 |
| 143 | fervidicoccaceae | 1 |
| 144 | fragment-derived | 1 |
| 145 | g1-β- | 1 |
| 146 | gansky | 1 |
| 147 | gap-on-wall | 1 |
| 148 | garg | 1 |
| 149 | gem+ | 1 |
| 150 | gindi | 1 |
| 151 | graded-maintenance-dose | 1 |
| 152 | gribble | 1 |
| 153 | guileful | 1 |
| 154 | hairpin-containing | 1 |
| 155 | hanse | 1 |
| 156 | hdac-mediated | 1 |
| 157 | heparin-bound | 1 |
| 158 | high-cholesterol-fed | 1 |
| 159 | hyperosteogeny | 1 |
| 160 | hébert | 1 |
| 161 | idd9.3-encoded | 1 |
| 162 | ifn-i-independent | 1 |
| 163 | igt/low | 1 |
| 164 | il-2/ | 1 |
| 165 | immunomodulator-treated | 1 |
| 166 | improve/develop | 1 |
| 167 | improveing | 1 |
| 168 | iothalamte | 1 |
| 169 | izar | 1 |
| 170 | jawale | 1 |
| 171 | jobbins | 1 |
| 172 | k=313 | 1 |
| 173 | kilgard | 1 |
| 174 | kunkhouser | 1 |
| 175 | l178 | 1 |
| 176 | lambrusco | 3 |
| 177 | leitão | 1 |
| 178 | leu412рhe | 1 |
| 179 | limberger | 1 |
| 180 | lopinavir-naive | 2 |
| 181 | lvdp/ | 1 |
| 182 | m1-associated | 1 |
| 183 | m2,3-edge | 2 |
| 184 | mac-t. | 1 |
| 185 | madni | 1 |
| 186 | makhija | 1 |
| 187 | mapquant | 1 |
| 188 | mattar | 1 |
| 189 | mdrd-estimated | 1 |
| 190 | memantine-an | 1 |
| 191 | membrano-proliferative | 1 |
| 192 | menezes | 1 |
| 193 | mental-physical | 2 |
| 194 | microparticle-bound | 3 |
| 195 | mid-posterior-leaflet | 1 |
| 196 | middilution | 1 |
| 197 | midinspiratory | 1 |
| 198 | mir-155-regulated | 1 |
| 199 | mmc/ | 1 |
| 200 | mmef25-75 | 2 |
| 201 | moving-table | 2 |
| 202 | multimuscle | 1 |
| 203 | murdoch | 2 |
| 204 | más | 1 |
| 205 | n-disubstituted | 2 |
| 206 | neccesitating | 1 |
| 207 | nehra | 1 |
| 208 | ngt/high | 1 |
| 209 | nicabate | 1 |
| 210 | nnos-derived | 2 |
| 211 | non-assuring | 1 |
| 212 | non-cell-bound | 1 |
| 213 | non-hiv-1-infected | 1 |
| 214 | non-pci-related | 1 |
| 215 | non-ta-assisted | 2 |
| 216 | noncarbamylating | 1 |
| 217 | nongeldanamycin | 1 |
| 218 | nonglycated | 1 |
| 219 | nonhydrolyzing | 1 |
| 220 | noninfarct-zone | 1 |
| 221 | ntsr2-mediated | 1 |
| 222 | nutrition..do | 1 |
| 223 | nvb+ | 1 |
| 224 | nóbrega | 1 |
| 225 | ochiai | 1 |
| 226 | omeprazole/5-hydroxy | 1 |
| 227 | oral-sex | 1 |
| 228 | orx+high-dose | 1 |
| 229 | orx+low-dose | 1 |
| 230 | outlives | 1 |
| 231 | over-activates | 1 |
| 232 | over-exceeding | 1 |
| 233 | p.w206x | 2 |
| 234 | palakkad- | 1 |
| 235 | palmitate-stimulated | 1 |
| 236 | paramita | 1 |
| 237 | pdea11 | 1 |
| 238 | peak-stress | 1 |
| 239 | pharr | 1 |
| 240 | phospho-ser474 | 1 |
| 241 | phosphor-p38 | 1 |
| 242 | phytopharm | 1 |
| 243 | pi3kβ-deficient | 1 |
| 244 | pi3kβ-knockdown | 1 |
| 245 | pkcδ-induced | 1 |
| 246 | polfa-lodz | 1 |
| 247 | post-laiv | 1 |
| 248 | postoperatively.in | 1 |
| 249 | potentalize | 1 |
| 250 | poulsen | 1 |
| 251 | poulter | 1 |
| 252 | preble | 1 |
| 253 | preenting | 1 |
| 254 | proclining | 1 |
| 255 | promutagen | 1 |
| 256 | proteqflu | 1 |
| 257 | protrombin | 3 |
| 258 | providing-for | 1 |
| 259 | prpf | 1 |
| 260 | psi-driven | 1 |
| 261 | psychother | 1 |
| 262 | putrid-smelling | 1 |
| 263 | pwa=14 | 1 |
| 264 | quarantining | 1 |
| 265 | quieting | 2 |
| 266 | rajagopalan | 1 |
| 267 | rathore | 1 |
| 268 | rct-treatment | 1 |
| 269 | re-emphasizing | 1 |
| 270 | receptor-reactive | 1 |
| 271 | respectively.for | 1 |
| 272 | respectively.the | 18 |
| 273 | reunifying | 1 |
| 274 | rewriting | 1 |
| 275 | roissy | 1 |
| 276 | rovimix | 1 |
| 277 | rs11191439 | 1 |
| 278 | rs3740393 | 1 |
| 279 | ryser | 1 |
| 280 | rzdz | 1 |
| 281 | s1pr2-deficient | 1 |
| 282 | saline/querc | 3 |
| 283 | saran | 3 |
| 284 | sasikumar | 1 |
| 285 | schlaff | 1 |
| 286 | schlant | 1 |
| 287 | screen-writers | 1 |
| 288 | second-quarter | 2 |
| 289 | sehlare | 1 |
| 290 | ser386-phosphorylated | 1 |
| 291 | sexhsp74and | 1 |
| 292 | shijiazhuang | 1 |
| 293 | showcasing | 1 |
| 294 | shrna-targeting | 1 |
| 295 | shugars | 1 |
| 296 | sildenafil-related | 1 |
| 297 | simoes | 1 |
| 298 | smyth | 1 |
| 299 | software-supported | 2 |
| 300 | sol-based | 1 |
| 301 | solomkin | 1 |
| 302 | spore-adsorbed | 1 |
| 303 | sposito | 1 |
| 304 | sr-theophylline | 1 |
| 305 | stablize | 1 |
| 306 | stadler | 1 |
| 307 | staphylococcusaureus-derived | 1 |
| 308 | stauffacher | 1 |
| 309 | steering/braking | 1 |
| 310 | supella | 1 |
| 311 | superinduced | 1 |
| 312 | suryavanshi | 2 |
| 313 | susrut | 1 |
| 314 | t482a/s484a | 1 |
| 315 | tamping | 1 |
| 316 | tangled | 1 |
| 317 | taurine-supplemented | 2 |
| 318 | technometrics | 1 |
| 319 | tg2-dependent | 1 |
| 320 | tgfβ1-stimulated | 1 |
| 321 | thai-language | 1 |
| 322 | tnf-α-enhanced | 1 |
| 323 | to0.145 | 1 |
| 324 | tohfat | 1 |
| 325 | tolerance-free | 1 |
| 326 | total/individual | 1 |
| 327 | trans11 | 6 |
| 328 | traxel | 1 |
| 329 | tryphostin | 1 |
| 330 | tvsp-induced | 4 |
| 331 | ultra-longacting | 2 |
| 332 | varty | 2 |
| 333 | vdand | 1 |
| 334 | veazie | 1 |
| 335 | vegf-stimulated | 1 |
| 336 | vollmer | 1 |
| 337 | vrana | 1 |
| 338 | well-above | 1 |
| 339 | welwyn | 1 |
| 340 | wheras | 3 |
| 341 | whereas | 24,933 |
| 342 | whereat | 1 |
| 343 | worley | 2 |
| 344 | xinzhen | 1 |
| 345 | zaidi | 1 |
| 346 | δload | 6 |
| 347 | ∆camk-4 | 1 |
| 348 | ∑alkylated | 1 |
| 1 | nvb+ | 1 |
| 2 | emf+ | 3 |
| 3 | gem+ | 1 |
| 4 | palakkad- | 1 |
| 5 | cholester- | 1 |
| 6 | g1-β- | 1 |
| 7 | mac-t. | 1 |
| 8 | il-2/ | 1 |
| 9 | mmc/ | 1 |
| 10 | lvdp/ | 1 |
| 11 | -133.00 | 1 |
| 12 | -135.00 | 1 |
| 13 | 4,030 | 2 |
| 14 | 19,290 | 1 |
| 15 | 1.2.3.1 | 1 |
| 16 | 37,611 | 1 |
| 17 | pdea11 | 1 |
| 18 | trans11 | 6 |
| 19 | 27,752 | 1 |
| 20 | 381,282 | 1 |
| 21 | cao2/ccvo2 | 1 |
| 22 | k=313 | 1 |
| 23 | rs3740393 | 1 |
| 24 | ∆camk-4 | 1 |
| 25 | 19,878.7-22,661.4 | 1 |
| 26 | pwa=14 | 1 |
| 27 | -7734 | 2 |
| 28 | 7444 | 2 |
| 29 | 5.764 | 1 |
| 30 | phospho-ser474 | 1 |
| 31 | -774 | 2 |
| 32 | anti-il-15r/il-15 | 1 |
| 33 | 10,815 | 1 |
| 34 | to0.145 | 1 |
| 35 | mmef25-75 | 2 |
| 36 | 135-75 | 1 |
| 37 | c12–c16 | 1 |
| 38 | 58,146 | 1 |
| 39 | 0.819646 | 1 |
| 40 | '56 | 1 |
| 41 | 70/166 | 1 |
| 42 | 5/166 | 1 |
| 43 | 75/166 | 1 |
| 44 | 79/166 | 1 |
| 45 | -686 | 2 |
| 46 | 19,960.3-23,150.7 | 1 |
| 47 | 11,537 | 1 |
| 48 | 195-267 | 1 |
| 49 | 25,777 | 1 |
| 50 | *2-*8 | 2 |
| 51 | phosphor-p38 | 1 |
| 52 | l178 | 1 |
| 53 | 3,878 | 2 |
| 54 | 9398 | 2 |
| 55 | 79.22∼139.09 | 1 |
| 56 | rs11191439 | 1 |
| 57 | 4,149 | 2 |
| 58 | 0.139449 | 1 |
| 59 | 5,359 | 1 |
| 60 | t482a/s484a | 1 |
| 61 | nóbrega | 1 |
| 62 | makhija | 1 |
| 63 | supella | 1 |
| 64 | asthana | 1 |
| 65 | vrana | 1 |
| 66 | nehra | 1 |
| 67 | 9beta | 1 |
| 68 | paramita | 1 |
| 69 | alva | 2 |
| 70 | amervac | 1 |
| 71 | saline/querc | 3 |
| 72 | 5g/d | 1 |
| 73 | dilshad | 1 |
| 74 | δload | 6 |
| 75 | assad | 1 |
| 76 | fayad | 1 |
| 77 | spore-adsorbed | 1 |
| 78 | tnf-α-enhanced | 1 |
| 79 | adma-induced | 1 |
| 80 | atrium-induced | 1 |
| 81 | tvsp-induced | 4 |
| 82 | pkcδ-induced | 1 |
| 83 | superinduced | 1 |
| 84 | am-produced | 1 |
| 85 | idd9.3-encoded | 1 |
| 86 | feed-and-bleed | 1 |
| 87 | high-cholesterol-fed | 1 |
| 88 | alanine-charged | 1 |
| 89 | density-enriched | 1 |
| 90 | cradled | 1 |
| 91 | tangled | 1 |
| 92 | aptt-controlled | 1 |
| 93 | code-named | 1 |
| 94 | 'wormed | 1 |
| 95 | ar-contained | 1 |
| 96 | cordycepin-impaired | 1 |
| 97 | fermentation-impaired | 1 |
| 98 | doppler-monitored | 1 |
| 99 | coherence-based | 1 |
| 100 | 3,5-dinitrobenzoate-based | 1 |
| 101 | sol-based | 1 |
| 102 | nonglycated | 1 |
| 103 | immunomodulator-treated | 1 |
| 104 | already-treated | 1 |
| 105 | m1-associated | 1 |
| 106 | deltanp63α-associated | 1 |
| 107 | ntsr2-mediated | 1 |
| 108 | hdac-mediated | 1 |
| 109 | cih-mediated | 1 |
| 110 | non-pci-related | 1 |
| 111 | sildenafil-related | 1 |
| 112 | mir-155-regulated | 1 |
| 113 | tgfβ1-stimulated | 1 |
| 114 | palmitate-stimulated | 1 |
| 115 | vegf-stimulated | 1 |
| 116 | ∑alkylated | 1 |
| 117 | ser386-phosphorylated | 1 |
| 118 | desphospho-carboxylated | 1 |
| 119 | 'estimated | 1 |
| 120 | mdrd-estimated | 1 |
| 121 | abrograted | 1 |
| 122 | non-hiv-1-infected | 1 |
| 123 | dsrna-elicited | 1 |
| 124 | exposited | 1 |
| 125 | taurine-supplemented | 2 |
| 126 | egf-promoted | 1 |
| 127 | software-supported | 2 |
| 128 | non-ta-assisted | 2 |
| 129 | n-disubstituted | 2 |
| 130 | 3dste-derived | 1 |
| 131 | nnos-derived | 2 |
| 132 | staphylococcusaureus-derived | 1 |
| 133 | fragment-derived | 1 |
| 134 | carboxylate-functionalized | 1 |
| 135 | cyano-functionalized | 1 |
| 136 | 27-week-old | 1 |
| 137 | sexhsp74and | 1 |
| 138 | vdand | 1 |
| 139 | microparticle-bound | 3 |
| 140 | non-cell-bound | 1 |
| 141 | heparin-bound | 1 |
| 142 | kilgard | 1 |
| 143 | fervidicoccaceae | 1 |
| 144 | coube | 1 |
| 145 | tolerance-free | 1 |
| 146 | biosafe | 1 |
| 147 | thai-language | 1 |
| 148 | m2,3-edge | 2 |
| 149 | dadhe | 1 |
| 150 | respectively.the | 18 |
| 151 | leu412рhe | 1 |
| 152 | veazie | 1 |
| 153 | jawale | 1 |
| 154 | moving-table | 2 |
| 155 | gribble | 1 |
| 156 | preble | 1 |
| 157 | multimuscle | 1 |
| 158 | 10-hole | 1 |
| 159 | corimoxazole | 1 |
| 160 | sr-theophylline | 1 |
| 161 | noninfarct-zone | 1 |
| 162 | dsred-type | 1 |
| 163 | sehlare | 1 |
| 164 | rathore | 1 |
| 165 | hanse | 1 |
| 166 | graded-maintenance-dose | 1 |
| 167 | orx+high-dose | 1 |
| 168 | orx+low-dose | 1 |
| 169 | nicabate | 1 |
| 170 | erradicate | 1 |
| 171 | iothalamte | 1 |
| 172 | lopinavir-naive | 2 |
| 173 | cd34-negative | 1 |
| 174 | membrano-proliferative | 1 |
| 175 | receptor-reactive | 1 |
| 176 | dildl-lectin-positive | 1 |
| 177 | well-above | 1 |
| 178 | potentalize | 1 |
| 179 | stablize | 1 |
| 180 | schlaff | 1 |
| 181 | prpf | 1 |
| 182 | 47mg | 1 |
| 183 | 38mg | 1 |
| 184 | shijiazhuang | 1 |
| 185 | over-exceeding | 1 |
| 186 | coseeding | 1 |
| 187 | improveing | 1 |
| 188 | 'changing | 3 |
| 189 | steering/braking | 1 |
| 190 | putrid-smelling | 1 |
| 191 | ergotamine-containing | 1 |
| 192 | hairpin-containing | 1 |
| 193 | proclining | 1 |
| 194 | quarantining | 1 |
| 195 | tamping | 1 |
| 196 | non-assuring | 1 |
| 197 | showcasing | 1 |
| 198 | crag-expressing | 1 |
| 199 | dmyc-overexpressing | 1 |
| 200 | 'crossing | 1 |
| 201 | collocating | 1 |
| 202 | noncarbamylating | 1 |
| 203 | aerating | 1 |
| 204 | neccesitating | 1 |
| 205 | attenutating | 1 |
| 206 | ultra-longacting | 2 |
| 207 | shrna-targeting | 1 |
| 208 | quieting | 2 |
| 209 | rewriting | 1 |
| 210 | preenting | 1 |
| 211 | alimenting | 1 |
| 212 | connoting | 1 |
| 213 | reunifying | 1 |
| 214 | 'enjoying | 2 |
| 215 | re-emphasizing | 1 |
| 216 | nonhydrolyzing | 1 |
| 217 | garg | 1 |
| 218 | 50µg | 1 |
| 219 | 0.01μg | 1 |
| 220 | afterwhich | 1 |
| 221 | 0.020-inch | 1 |
| 222 | murdoch | 2 |
| 223 | 1967-march | 1 |
| 224 | ngt/high | 1 |
| 225 | bequeath | 1 |
| 226 | 2011-with | 1 |
| 227 | smyth | 1 |
| 228 | ochiai | 1 |
| 229 | zaidi | 1 |
| 230 | gindi | 1 |
| 231 | amaechi | 1 |
| 232 | suryavanshi | 2 |
| 233 | cadmi | 1 |
| 234 | madni | 1 |
| 235 | farma-lepori | 1 |
| 236 | mental-physical | 2 |
| 237 | total/individual | 1 |
| 238 | traxel | 1 |
| 239 | gap-on-wall | 1 |
| 240 | guileful | 1 |
| 241 | fatai-nyl | 1 |
| 242 | 55ppm | 1 |
| 243 | phytopharm | 1 |
| 244 | memantine-an | 1 |
| 245 | rajagopalan | 1 |
| 246 | saran | 3 |
| 247 | promutagen | 1 |
| 248 | xinzhen | 1 |
| 249 | poulsen | 1 |
| 250 | psi-driven | 1 |
| 251 | postoperatively.in | 1 |
| 252 | protrombin | 3 |
| 253 | diblocin | 1 |
| 254 | nongeldanamycin | 1 |
| 255 | 16,16-dimethyl-prostaglandin | 1 |
| 256 | -dimethylprostaglandin | 1 |
| 257 | solomkin | 1 |
| 258 | breslin | 1 |
| 259 | anemarsaponin | 9 |
| 260 | tryphostin | 1 |
| 261 | middilution | 1 |
| 262 | euron | 1 |
| 263 | pi3kβ-knockdown | 1 |
| 264 | welwyn | 1 |
| 265 | lambrusco | 3 |
| 266 | nutrition..do | 1 |
| 267 | double-echo | 1 |
| 268 | cezário | 1 |
| 269 | sposito | 1 |
| 270 | leitão | 1 |
| 271 | 27bp | 1 |
| 272 | improve/develop | 1 |
| 273 | cardular | 1 |
| 274 | sasikumar | 1 |
| 275 | abraso-star | 1 |
| 276 | mattar | 1 |
| 277 | izar | 1 |
| 278 | brunengraber | 2 |
| 279 | limberger | 1 |
| 280 | stauffacher | 1 |
| 281 | psychother | 1 |
| 282 | stadler | 1 |
| 283 | beller | 1 |
| 284 | vollmer | 1 |
| 285 | buckner | 1 |
| 286 | kunkhouser | 1 |
| 287 | ryser | 1 |
| 288 | poulter | 1 |
| 289 | second-quarter | 2 |
| 290 | providing-for | 1 |
| 291 | respectively.for | 1 |
| 292 | essentialfor | 1 |
| 293 | abnor | 1 |
| 294 | pharr | 1 |
| 295 | whereas | 24,933 |
| 296 | wheras | 3 |
| 297 | technometrics | 1 |
| 298 | dodds | 1 |
| 299 | simoes | 1 |
| 300 | over-activates | 1 |
| 301 | outlives | 1 |
| 302 | menezes | 1 |
| 303 | equilis | 4 |
| 304 | jobbins | 1 |
| 305 | erythrophlesins | 1 |
| 306 | shugars | 1 |
| 307 | screen-writers | 1 |
| 308 | peak-stress | 1 |
| 309 | más | 1 |
| 310 | whereat | 1 |
| 311 | tohfat | 1 |
| 312 | mid-posterior-leaflet | 1 |
| 313 | schlant | 1 |
| 314 | crepitant | 2 |
| 315 | mapquant | 1 |
| 316 | dlg1-dependent | 1 |
| 317 | tg2-dependent | 1 |
| 318 | caveolin-1/galectin-3-dependent | 1 |
| 319 | ageing-dependent | 1 |
| 320 | c-rel-dependent | 1 |
| 321 | ifn-i-independent | 1 |
| 322 | s1pr2-deficient | 1 |
| 323 | pi3kβ-deficient | 1 |
| 324 | rct-treatment | 1 |
| 325 | hébert | 1 |
| 326 | 6-but | 2 |
| 327 | susrut | 1 |
| 328 | proteqflu | 1 |
| 329 | post-laiv | 1 |
| 330 | igt/low | 1 |
| 331 | byblow | 1 |
| 332 | p.w206x | 2 |
| 333 | oral-sex | 1 |
| 334 | rovimix | 1 |
| 335 | cellerix | 1 |
| 336 | betamox | 1 |
| 337 | worley | 2 |
| 338 | gansky | 1 |
| 339 | espacially | 1 |
| 340 | antidepressants-especially | 1 |
| 341 | hyperosteogeny | 1 |
| 342 | midinspiratory | 1 |
| 343 | roissy | 1 |
| 344 | varty | 2 |
| 345 | omeprazole/5-hydroxy | 1 |
| 346 | polfa-lodz | 1 |
| 347 | rzdz | 1 |
| 348 | 9β | 1 |